Optasia Medical applies model-based vision technology to problems in musculoskeletal disease; in particular, for the detection and monitoring of osteoporosis, osteoarthritis and rheumatoid arthritis, as well as to the planning and assessment of orthopaedic surgery.

We develop solutions for clinical trials and point-of-care physicians. Our products are deployed through Imaging Core Labs, OEMs and direct sales worldwide. Optasia Medical serves the healthcare and clinical trials market via a dedicated team of scientists and business professionals with sector-specific expertise. Optasia Medical is committed to providing leading edge vision technology to serve our customers’ needs for innovative image analysis solutions.